{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

Mullen (NASDAQ: MULN) Subsidiary Gains ‘Strong Foothold’ in California’s Central Valley

September 12, 2024 Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that its subsidiary, Bollinger Motors, has added Affinity Truck Center, a family-owned business founded in 1980, to its retail network. As a result, Affinity, which operates sales locations in Bakersfield and Fresno, California, as well as service locations in Paso Robles and Salinas, California, is now an official Bollinger Motors dealer.


Mullen (NASDAQ: MULN) Subsidiary Achieves ‘Important Accomplishment’ with CARB Certification

September 10, 2024 Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that its subsidiary, Bollinger Motors, has received certification from the California Air Resources Board (“CARB”) for its B4 all-electric, Class 4 low forward chassis truck. The CARB certification is a requirement to sell vehicles in California, Colorado, Connecticut, Delaware, Maine, Maryland, Massachusetts, New Jersey, New Mexico, New York, Oregon, Pennsylvania, Rhode Island, Vermont and the District of Columbia.


Clene (NASDAQ: CLNN) Seeks to Transform Neurodegenerative Disorder Treatments

September 9, 2024 With a focus on improving mitochondrial health, CNM-Au8® stands out among other therapies by targeting the nicotinamide adenine dinucleotide pathway to restore and protect neurological function. Nearly 2 million Americans are affected by amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”) or Parkinson’s disease.


Mullen (NASDAQ: MULN) Subsidiary Inks Partnership Agreement with TCD

September 6, 2024 Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has entered into a partnership agreement with Texas Consulting & Development LLC (“TCD”). According to the agreement, Bollinger will provide TCD with Bollinger B4 Class 4 trucks as part of TCD’s new, bundled service offering to ports and other related industries while TCD will leverage the Bollinger B4 to increase sales across an array of sectors, including commercial & industrial, telecom and utility.


Mullen (NASDAQ: MULN) Completes First Shipment of Vehicles Purchased by Volt Mobility

September 5, 2024 Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, announced the initial shipment of vehicles to fulfill a $210 million purchase contract with Volt Mobility, which is based in the United Arab Emirates (“UAE”). Volt has purchased 3,000 Mullen Class 1 and Class 3 EV cargo vans and trucks to be delivered over a 16-month period.


Clene (NASDAQ: CLNN) Management to Present at H.C. Wainwright Investment Conference

September 4, 2024 Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc. , is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”).


D-Wave Quantum (NYSE: QBTS) Extends Quantum AI Product Roadmap

September 4, 2024 The extended product roadmap is part of the company’s efforts to strengthen the connection between quantum optimization, AI and Machine Learning (“ML”), in order to bring new Quantum Artificial Intelligence (“AI”) solutions to market D-Wave’s annealing quantum computing solutions could play a key role in improving AI/ML with more efficient model training, reduced energy consumption, and faster time-to-solution The company’s Quantum AI solutions could be transformative, bringing a powerful new set of new computing tools for generative AI D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the first commercial provider of quantum computers, was featured in a NetworkNewsAudio syndicated broadcast highlighting the company’s extended quantum AI product roadmap and enhancements to its Leap(TM) quantum cloud service. The audio broadcast can be heard at: https://ibn.


Clene (NASDAQ: CLNN) Positioned as Leader in Addressing Neurodegenerative Diseases

September 3, 2024 Clene (NASDAQ: CLNN), a biopharmaceutical company, is at the forefront of transforming the treatment of neurodegenerative disorders like amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). “Clene’s lead agent, CNM-Au8, targets the nicotinamide adenine dinucleotide (‘NAD+’) pathway to restore and protect neurological function.


Clene (NASDAQ: CLNN) CEO Discusses CNM-Au8(R) Trial Results on BioMedWire Podcast

August 29, 2024Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, was recently featured on The BioMedWire Podcast, highlighting the important results of CNM-Au8 trials for both amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), and plans for the future (https://ibn.fm/6OOO1). During the podcast, CEO […]


Lexaria (NASDAQ: LEXX) Validates Tech’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market

August 27, 2024Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released findings from its applied research program that sought to evaluate the mode of action facets of its patented DehydraTECH(TM) technology and the glucagon-like peptide 1 (“GLP-1”) drug, semaglutide. The program was conducted in conjunction with the National Research Council of Canada (“NRC”), […]This press release is distributed by InvestorBrandNetwork (IBN).


SuperCom (NASDAQ: SPCB) Reports Q2, H1 Earnings Growth, Record Profit

August 27, 2024Electronic monitoring (“EM”) technology innovator SuperCom (NASDAQ: SPCB) is celebrating impressive developments in 2024, reporting “substantial improvements” in its gross profit, operating income, and net income as it secures new orders and contracts from government and judicial system clients. SuperCom’s technology development and deployment are strategically focused on providing EM tools for tracking offenders supervised by nations’ […]This press release is distributed by InvestorBrandNetwork (IBN).


SenesTech (NASDAQ: SNES) Closes on $2.3M Warrant Exercise

August 27, 2024SenesTech (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, has closed on an exercise of certain existing warrants. The exercise consisted of purchasing 505,502 shares of the company’s common stock at a reduced exercise price of $4.